Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Stock Statistics & Valuation Metrics

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a market cap or net worth of HK$1.96B. The enterprise value is HK$745.26M.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.63%.

The current PE Ratio of Shanghai Heartcare Medical Technology Corp. Ltd. Class H is 43.3. Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s PEG ratio is 0.67.

In the last 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H had revenue of 277.90M and earned -13.62M in profits. Earnings per share was -0.36.

In the last 12 months, operating cash flow was 41.60M and capital expenditures -11.05M, giving a free cash flow of 30.56M billion.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Shanghai Heartcare Medical Technology Corp. Ltd. Class H upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).

Shanghai Heartcare Medical Technology Corp. Ltd. Class H as a current ratio of 12.42, with Debt / Equity ratio of 4.12%

In the past 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has paid 1.63M in taxes.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H EV to EBITDA ratio is 9.72, with an EV/FCF ratio of -25.32.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H has HK$718.20M in cash and marketable securities with HK$45.91M in debt, giving a net cash position of HK$672.29M billion.

Gross margin is 67.49%, with operating margin of -2.24%, and net profit margin of -4.90%.

The average price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is Hold